ALFA Filings
Every announcement, straight from the exchange
Every Akums Drugs & Pharmaceuticals results update announcement on NSE and BSE, newest first, each with its own page.
Time
3 announcements
Akums reported Q2 FY27 revenue of ₹1,342 crore, up 31.9%, and PAT of ₹115 crore, up 168%. The release is a press update with highlights, not the full results statement.
Akums Drugs reported Q1 FY27 consolidated revenue of ₹1,167 crore, reflecting 13.9% year-on-year growth. PAT rose to ₹101 crore compared to ₹65 crore in Q1 FY26.
Akums Drugs reported ₹1,158 Crore Q4 revenue, marking 9.7% growth. Strong performance in CDMO business drove significant margin improvement and profitability for FY26.